Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Study Overview Amgen is launching a Phase 3 trial ...

When the hair rises on the back of your neck through a process called piloerection or something hurts so much your primitive response prompts you to run away, your body can completely block out pain ...

Background Fermented foods are a promising yet underexplored intervention for influencing brain function and mental health through the gut–brain axis. Objective The objective of this study was to ...

A potential vaccine against the deadly Nipah virus has shown encouraging safety and immune responses in an early human trial, ...

Kimchi may do far more than add flavor to meals—it could help fine-tune the human immune system. A clinical study using advanced single-cell genetic analysis found that regular kimchi consumption ...

It comes on the heels of the CDC Advisory Council on Immunization Practices eliminating long-standing recommendations for hepatitis B vaccines for newborns. Health Secretary Robert F. Kennedy Jr.

Innovation in ophthalmology is often measured by what reaches the clinic—but the path to those breakthroughs begins much ...

Phase 1 data confirms SAB-142 does not cause serum sickness and has low/no immunogenicity at any dose and in all cohorts, including redosed ...

About GLPG3667, the GALARISSO (NCT: 05695950) and GALACELA (NCT: 05856448) studies GLPG3667 is an investigational reversible and selective tyrosine kinase 2 (TYK2) kinase domain inhibitor currently ...

Organogenesis Holdings ($ORGO) announced an update on their ongoing clinical study. Study Overview Organogenesis Holdings (ORGO) is sponsoring a ...

A new international online survey published in the Journal of Affective Disorders gives voice to the lived experiences of ...

Houston-area clinical research organization Hope Biosciences Research Foundation (HBRF) today shares positive top-line results of a Phase II clinical trial to evaluate Hope Biosciences' allogeneic ...